Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related HW
A Peek Into The Markets: U.S. Stock Futures Gain Ahead Of Economic Reports
7 Stocks To Watch For May 1, 2017
Related LLY
Eli Lilly's Taltz Gets Approval For Label Expansion in US
Who Is The Former Pharma Exec Trump Nominated To Lead HHS?
Novo Nordisk: An Update Based On Recent Newsflow (Seeking Alpha)


  • Jefferies downgraded Headwaters Inc (NYSE: HW) from Buy to Hold. Headwaters shares rose 0.19 percent to close at $23.57 on Wednesday.
  • Analysts at BMO Capital downgraded Eli Lilly and Co (NYSE: LLY) from Outperform to Market Perform. The price target for Eli Lilly has been lowered to $64. Eli Lilly shares rose 0.16 percent to $68.11 in pre-market trading.
  • SunTrust Robinson Humphrey downgraded Juno Therapeutics Inc (NASDAQ: JUNO) from Buy to Hold. The price target for Juno Therapeutics has been lowered from $48 to $25. Juno Therapeutics shares rose 1.95 percent to $23.00 in pre-market trading.
  • Atlantic Equities downgraded Eli Lilly and Co (NYSE: LLY) from Overweight to Neutral. Eli Lilly shares closed at $68.00 on Wednesday.

Latest Ratings for HW

Nov 2016JefferiesDowngradesBuyHold
Nov 2016Stifel NicolausDowngradesBuyHold
Nov 2016SunTrust Robinson HumphreyDowngradesBuyHold

View More Analyst Ratings for HW
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (HW + JUNO)

View Comments and Join the Discussion!

Partner Center